| P50 | author | Natalia de las Heras | Q59205786 |
| | Vicente Lahera | Q70157106 |
| | María Ángeles Aller | Q57470114 |
| P2093 | author name string | Javier Regadera | |
| | Jaime Arias | |
| | Maria-Paz Nava | |
| P2860 | cites work | The risk association between experimental portal hypertension and an aortic atherosclerosis-like disease | Q58455099 |
| | The Role of Angiotensin Type 1 Receptor in Inflammation and Endothelial Dysfunction | Q59746476 |
| | Bacterial translocation in acute and chronic portal hypertension | Q70768250 |
| | Measurement of portal–systemic shunting in the rat by using gamma-labeled microspheres | Q70782814 |
| | Allopurinol reduces bacterial translocation, intestinal mucosal lipid peroxidation, and neutrophil-derived myeloperoxidase activity in chronic portal hypertensive and common bile duct-ligated growing rats | Q71671328 |
| | Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men | Q79977671 |
| | Mast cells as mediators and modulators of atherogenesis | Q80336392 |
| | Mast cells promote atherosclerosis by releasing proinflammatory cytokines | Q80422792 |
| | Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension | Q81625368 |
| | The metabolic syndrome | Q82681399 |
| | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 |
| | The human microbiome: at the interface of health and disease | Q29614801 |
| | Gut Microbiota in Health and Disease | Q29616812 |
| | Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility | Q33901955 |
| | Mast cells and metabolic syndrome | Q35106076 |
| | Gut microbiota and inflammation | Q35670894 |
| | Mast cells as "tunable" effector and immunoregulatory cells: recent advances. | Q36072458 |
| | The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease | Q36310293 |
| | Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features | Q36372137 |
| | The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule | Q36382290 |
| | Inflammation: a way to understanding the evolution of portal hypertension. | Q36391634 |
| | Chronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome? | Q36487408 |
| | Animal models of portal hypertension | Q36640036 |
| | Molecular and structural basis of portal hypertension | Q36680434 |
| | The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. | Q36950557 |
| | Inflammatory mechanisms: the molecular basis of inflammation and disease | Q37073872 |
| | Role of inflammation in atherosclerosis associated with rheumatoid arthritis | Q37300182 |
| | The gut and intestinal bacteria in chronic heart failure | Q37370227 |
| | Nitric oxide, NAD(P)H oxidase, and atherosclerosis | Q37405595 |
| | Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis | Q37421814 |
| | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling | Q37451950 |
| | Angiogenesis in chronic liver disease and its complications | Q37809119 |
| | Role of mast cells in mucosal diseases: current concepts and strategies for treatment | Q38068961 |
| | CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. | Q39855226 |
| | The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea. | Q41666713 |
| | Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats | Q41848100 |
| | Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock | Q42512096 |
| | NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells | Q43064579 |
| | The gastrointestinal tract. The "undrained abscess" of multiple organ failure | Q43550431 |
| | Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats | Q44298647 |
| | The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. | Q44429830 |
| | Portal hypertension and its complications | Q44938217 |
| | Partial hepatectomy, partial portal vein stenosis and mesenteric lymphadenectomy increase splanchnic mast cell infiltration in the rat. | Q46009644 |
| | Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids. | Q46435946 |
| | Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis | Q46458998 |
| | Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis | Q46540178 |
| | A wound-like inflammatory aortic response in chronic portal hypertensive rats. | Q54316728 |
| | Human intestinal mast cells are a potent source of multiple chemokines. | Q54325833 |
| | Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats | Q56925338 |
| | Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats | Q57125016 |
| P433 | issue | 44 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| | portal hypertension | Q124604 |
| P304 | page(s) | 7992-7999 | |
| P577 | publication date | 2013-11-28 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Splanchnic-aortic inflammatory axis in experimental portal hypertension | |
| P478 | volume | 19 | |